Brief: Histogen Says Update For Its Hst-002 Dermal Filler Program
Sept 29 (Reuters) - Histogen Inc HSTO.O :
* HISTOGEN ANNOUNCES UPDATE FOR ITS HST-002 DERMAL FILLER
PROGRAM
* HISTOGEN INC - HST-001 1B/2A TRIAL FOR ANDROGENIC ALOPECIA
IN
MEN ON TRACK FOR TOP LINE DATA RESULTS IN 4Q20
* HISTOGEN INC - HST-003 IND SUBMISSION FOR REGENERATION OF
CARTILAGE IN KNEE EXPECTED 4Q20
Source text for Eikon: ID:nGNXDKpPn
Further company coverage: HSTO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Histogen
See all newsBrief: Histogen Announces Second Adjournment Of Special Meeting Of Stockholders
Brief: Histogen Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: Histogen Announces Board Approval Of Complete Liquidation And Dissolution
Histogen Inc expected to post a loss of 90 cents a share - Earnings Preview
Histogen to explore strategic options, shares up